AQP4 and neuromyelitis optica: All patients with TM should be tested for serum aquaporin-4-specific autoantibodies (NMO-IgG) and anti-MOG antibodies to rule out NMOSD and MOG antibody-associated demyelinating disease (MOGAD), respectively, as these may also present as TM, including longitudinally extending TM [20,21].